Minims Fluoresceine Sodique Bausch + Lomb Ireland Limited (Fluorescein Sodium)

Fluorescein sodium penetrates damaged epithelial cells on the eye’s surface. When illuminated with cobalt‑blue light, the dye fluoresces green, outlining areas of loss or disruption. This visual contrast enables clinicians to identify and document lesions, tears, or staining patterns accurately.

The appropriate dose of Minims Fluoresceine Sodique is determined by the prescribing eye care professional. Typically, a single drop is instilled onto the ocular surface, but the exact volume and frequency depend on the specific diagnostic procedure and patient needs.

Safety data for fluorescein sodium in pregnancy and lactation are limited. It is classified as pregnancy category unknown, so it should be used only if the potential benefit justifies any possible risk to the fetus or infant. Consultation with a healthcare provider is essential.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details and any necessary import documentation.

Fluorescein sodium is the most widely used ophthalmic diagnostic dye due to its strong fluorescence, safety profile, and ease of use. Alternatives such as lissamine green or rose bengal may be chosen for specific indications, but fluorescein remains the standard for routine corneal and conjunctival staining.

Store the ophthalmic solution at room temperature, preferably below 25 °C, in its original container. Protect it from direct sunlight, excessive heat and moisture. Ensure the cap is tightly closed to maintain sterility and prevent evaporation.

The product is administered as an ophthalmic solution. The prescriber typically instills a single drop onto the conjunctival sac of the eye being examined. After application, the clinician illuminates the eye with cobalt‑blue light to visualise the fluorescence.

Serious risks, although rare, include severe allergic reactions such as angioedema or anaphylaxis, significant ocular inflammation, and corneal edema. Patients should be monitored for any signs of systemic hypersensitivity or worsening ocular symptoms and seek immediate medical attention if they occur.

Individuals with a known hypersensitivity to fluorescein sodium or any component of the formulation should avoid using the product. It is also contraindicated in patients who have experienced severe reactions to other ophthalmic dyes or who have active ocular infections that could be exacerbated by dye application.